Technological

Watch

Powered by:

NEW

Direct Investment in China

BASF‚??s venture investment will enable Prismlab to further accelerate its product development, which is visibly pleasing to employees (¬© BASF)

BASF Venture Capital GmbH, Ludwigshafen, Germany, is investing in Prismlab, a provider of 3D printing processes and 3D printers, headquartered in Shanghai, China. Prismlab has developed a patented printing process that is characterized by a very high printing speed, high level of precision and lower printing costs. BASF‚??s venture investment will enable Prismlab to further accelerate its product development and innovation while strengthening its market reach to the global market.

The company has developed a patented 3D printing process, ‚??Pixel Resolution Enhanced Technology‚?Ě, based on stereolithography (SLA). SLA allows comparatively large components to be produced using light-curing resins. The technology increases the printing resolution without compromising printing speed.

Numerous Parts in the Same Production Step

‚??This is our first direct investment in a Chinese company. " Markus Solibieda, Managing Director of BASF Venture Capital (¬© BASF)

In order to increase the amount of energy brought into a pixel, Prismlab‚??s technology divides each pixel in the resin into several small sections, which can be cured individually by exposure to LCD light. This makes the energy input into each pixel significantly higher than similar processes that expose each pixel to light once. This allows comparatively large and stable components or numerous parts to be printed in the same production step. With the use of LCD light, it also reduces process costs. This advantage should open opportunities in the footwear and furniture industry.

Along with this patented process, Prismlab also markets 3D printers and other related services. The technology can be used in various key customer applications, including invisible braces, and anatomical models for medical, and education and training purposes.

First Direct Investment in a Chinese Company

‚??This is our first direct investment in a Chinese company,‚?Ě said Markus Solibieda, Managing Director of BASF Venture Capital GmbH. ‚??The trailblazing technology from Prismlab allows large and stable components, such as medical braces and anatomical models, to be 3D printed for the first time. This investment supports BASF‚??s strategy of actively advancing our technologies and expanding our product offering in the 3D printing sector.‚?Ě

» More Information

« Go to Technological Watch

LATEST NEWS TECHNOLOGICAL WATCH

[15/11/2018] - Johnson Controls reaches $13.2 billion deal to sell its auto battery unit

[15/11/2018] - Rocket Lab reaches orbit again, deploys more satellites

[15/11/2018] - House of Lords report calls for urgent clarification on chemicals regulation post-Brexit / Concerns on REACH registrations and data

[15/11/2018] - New web pages to prepare companies for UKís withdrawal from EU

This project has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement nį [310187].